The North America Chromatography Instruments Market is expected to witness robust growth between 2020 and 2035, driven by innovation in analytical technologies and increasing application in pharmaceuticals and biotechnology industries. With rising adoption of advanced liquid chromatography and government initiatives supporting drug development, the market is set to expand significantly.
The economic impact of tariffs on "North America Chromatography Instruments Market".
Market Growth Drivers
Expansion of biopharmaceutical R&D activities: The growth of biopharmaceutical research, particularly in the US, is a significant factor driving the demand for chromatography instruments. Companies such as Thermo Fisher Scientific and Agilent Technologies have reported increased sales in liquid chromatography equipment, fueled by the need for advanced analysis in drug discovery and biologics production. The industry is investing heavily in research and development, and strict quality regulations necessitate reliable analytical instruments, further bolstering demand across North America.
Increasing need for environmental and food safety testing: Rising pollution levels and concerns about food safety regulations have pushed government bodies and private labs to invest heavily in trace analysis. Waters Corporation, for example, has seen a surge in its mass spectrometry and chromatography instrument sales, driven by compliance requirements such as the Safe Drinking Water Act and FDA food safety modernization efforts. This trend is anticipated to continue as regulations tighten in both the United States and Canada.
Market Trends
Adoption of advanced LC-MS technologies: Chromatography instrument providers like Agilent Technologies and Shimadzu Scientific Instruments are increasingly integrating liquid chromatography with mass spectrometry (LC-MS) for enhanced analytical performance. This trend, fueled by requirements in clinical diagnostics and precision medicine, is seeing strong demand in hospital and laboratory settings, with manufacturers noting double-digit sales growth in LC-MS platforms across North America.
Rise of automation and digitalization: Key industry players are embedding IoT connectivity and artificial intelligence in chromatography systems to improve data quality and lab productivity. PerkinElmer has recently launched automated platforms that offer features such as remote monitoring and predictive maintenance. These technologies are enabling labs to operate more efficiently and meet the growing throughput demands of pharmaceutical and chemical analysis sectors.
Market Opportunity
Expansion of contract research and testing laboratories: As pharmaceutical and biotechnology companies increasingly outsource analytical and quality control testing, the demand for chromatography instruments from contract research organizations (CROs) is surging. Danaher Corporation’s Sciex and other leading players are expanding their offerings to cater to the specialized needs of these labs.
Growth in cannabis testing: With the legalization of medical and recreational cannabis in several US states and Canada, there is a growing need for robust testing solutions. Companies such as Shimadzu are capitalizing on this opportunity by providing comprehensive chromatography systems for cannabinoid profiling, pesticide screening, and contaminant testing.
North America Chromatography Instruments Market Revenue (2020-2035)
The market has shown steady growth, with revenue rising from USD 2,300 million in 2020 to an anticipated USD 5,710 million in 2035. This trajectory is attributed to expanding biopharmaceutical R&D spending, stricter regulatory requirements, and the development of advanced chromatography solutions tailored to pharmaceutical, environmental, and food safety applications. Notably, between 2024 and 2030, the CAGR is estimated at 7.2%, reflecting technological advancements and market expansion. The upward trend is expected to continue, with large investments in automation and digital integration accelerating market size through 2035.
North America Chromatography Instruments Market by Region, 2025
In 2025, the United States holds the dominant share of the North America chromatography instruments market, capturing 74% due to its large pharmaceutical, biotechnology, and regulatory sectors. Canada follows with 18%, propelled by growing investments in healthcare research and stringent food safety initiatives. Mexico accounts for 6%, benefiting from cross-border manufacturing growth and regulatory modernization. Other minor regions in North America, including select Caribbean and Central American territories, collectively contribute about 2%. The distribution highlights the market's concentration in the US, though regional diversification is gradually increasing.
Recent Developments in the North America Chromatography Instruments Market
In May 2024, Thermo Fisher Scientific announced the commercial launch of its Vanquish Neo UHPLC system in North America, optimized for proteomics research and clinical diagnostics. This new instrument features enhanced throughput, sensitivity, and automated workflows, positioning Thermo Fisher as a technology leader in the expanding life sciences sector.
In April 2024, Agilent Technologies unveiled a new series of InfinityLab LC/MSD iQ systems with built-in smart diagnostics, aiming to reduce instrument downtime and enhance productivity. The new systems were rapidly adopted by both academic and commercial biotech labs across the US and Canada, reflecting strong market demand for automated maintenance and data management capabilities in chromatography.
In February 2024, Waters Corporation announced the acquisition of Wyatt Technology, strengthening its position in biotherapeutic characterization within North America. This move allows Waters to integrate Wyatt’s chromatography-light scattering detectors with its existing chromatography instruments, providing comprehensive solutions to customers engaged in protein and nucleic acid analysis.
Press Releases